Prion protein-derived cell-penetrating peptide inhibits type II diabetes-associated islet amyloid polypeptide aggregation and cytotoxicity
Yujeong Oh, Loganathan Palanikumar, Madeline Howarth, Debabrata Maity, Liaqat Ali, Morad Mustafa, Sunil Kumar, Andrew D. Hamilton, Mazin M. Magzoub
This study evaluates a cell-penetrating peptide (NCAM1-PrP) for its ability to inhibit IAPP aggregation and cytotoxicity in type II diabetes.
Biochemistry · Apr 2, 2026Peer-reviewedBiochemistry